Exocrine Pancreatic Adenocarcinoma
2 clinical trials · Condition
◉ Watch Exocrine Pancreatic Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| A Study of SGN-STNV in Advanced Solid Tumors (NCT04665921) | Seagen Inc. | 2021-01-18 |
| A Study of Sigvotatug Vedotin in Advanced Solid Tumors (NCT04389632) | Seagen, a wholly owned subsidiary of Pfizer | 2020-06-08 |
Track Exocrine Pancreatic Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.